PCSA
Processa Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.96
+3.16%Jul 29, 2026, 12:48 UTC
Processa Pharmaceuticals raised $200 million for drug trials.
Source:Jul 29, 2026, 12:48 UTC
Processa Pharmaceuticals acquired Vidya Therapeutics in an all-stock deal on Wednesday, gaining access to its lead candidate targeting immune system diseases.
Source: